COMMUNIQUÉS West-GlobeNewswire
-
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
17/06/2026 -
Precision Neuroscience™ Wins 2026 Webby Award; Earns Back-to-Back Fast Company World Changing Ideas Honor
17/06/2026 -
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
17/06/2026 -
BPGbio Presents Latest Clinical and Translational Findings Supporting BPM31510 in Primary CoQ10 Deficiency at Mito Med 2026
17/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17/06/2026 -
Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series
17/06/2026 -
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
17/06/2026 -
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
17/06/2026 -
MedX Holdings Accelerates Growth: Expanding Lazydaze Franchise Footprint, Unveiling Major Product Innovations, and Strengthening Brand Infrastructure
17/06/2026 -
Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data
17/06/2026 -
Christian Wichert appointed Chief Executive Officer to lead next phase of growth
17/06/2026 -
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
17/06/2026 -
Avricore Health Closes $1.254 Million Financing
17/06/2026 -
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026 -
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
17/06/2026 -
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
17/06/2026 -
NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth
17/06/2026 -
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
17/06/2026 -
BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free
17/06/2026
Pages